Insmed Inc.

05/15/2026 | Press release | Distributed by Public on 05/15/2026 14:03

Proxy Results (Form 8-K)

ITEM 5.07 - Submission of Matters to a Vote of Security Holders.

The annual meeting of shareholders of Insmed Incorporated (the "Company") was held on May 13, 2026 (the "Annual Meeting"). Set forth below are the voting results for each of the proposals submitted to a vote of the Company's shareholders at the Annual Meeting:

Proposal 1.
Election of Two Class II Directors.

By the following votes, shareholders elected Elizabeth McKee Anderson and Clarissa Desjardins, Ph.D., to serve as Class II directors until the Company's 2029 Annual Meeting of Shareholders:

For
Withheld
Broker Non-Votes
Elizabeth McKee Anderson
153,734,471
32,130,980
11,564,082
Clarissa Desjardins, Ph.D.
164,437,828
21,427,623
11,564,082

Proposal 2.
Advisory Vote on the 2025 Compensation of Named Executive Officers.

By the following vote, shareholders approved, on an advisory, non-binding basis, the 2025 compensation of our named executive officers, as disclosed in the Proxy Statement:

For
Against
Abstentions
Broker Non-Votes
162,133,728
23,657,325
74,398
11,564,082

Proposal 3.
Ratification of the Appointment of an Independent Registered Public Accounting Firm.

By the following vote, shareholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026:

For
Against
Abstentions
190,386,612
6,997,613
45,308

Insmed Inc. published this content on May 15, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on May 15, 2026 at 20:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]